Animal research and AI/BMI health predictors: News from Imperial
Imperial’s AI startups showcase ideas in Singapore
Climate risks from exceeding 1.5°C reduced if warming swiftly reversed
01 August 2024
New tool could transform study of cells and help find new drug targets
08 July 2024
Imperial and Crick cancer drug spinout raises £90m to begin clinical development
13 June 2024
Mathematics PhD student wins major science communication competition
01 April 2024
New synthesis platform allows for rapid cancer drug synthesis and testing
26 March 2024
Eight things we learned about commercialising medical research at AYCI 2024
07 March 2024
Impact of artificial intelligence on AMR: Common themes and challenges
11 January 2024
New class of cancer and immunology drug targets mapped with new tagging system
27 November 2023
Unraveling the Secrets of Zombie cells
16 November 2023
UK approves world-first gene-editing treatment for blood disorders
31 October 2023
New £28m Centre to forge the next generation of AI digital healthcare innovators
20 October 2023
Towards using quantum computing to speed up drug development
19 October 2023
New mechanism found that maintains water balance within cells
13 October 2023
Imperial President - College making big moves to accelerate medical innovation
06 September 2023
Apollo Therapeutics raises $226.5m to develop medicines based on uni research
21 August 2023
Nobel-winning bodily ‘pressure sensors’ filmed for first time at Imperial
20 July 2023
New database of drug targets will help fight incurable diseases
23 May 2023
Imperial and Agilent renew partnership for flagship analytical science facility
22 May 2023
New partnership will use molecular glues to tackle ‘undruggable’ disease targets
21 February 2023
Research shows how human cells are protected when the immune system switches on
20 February 2023
UV-light activated probe finds new interactions in living cells
14 February 2023
Professor Ed Tate appointed to the GSK Chair in Chemical Biology
22 January 2023
Wearable tech, AI and clinical teams join to change the face of trial monitoring
16 December 2022
Innovation and entrepreneurship at Imperial: A year in review
02 November 2022
CRISPR-based oligo recombineering in drug discovery